case report aspiration during anesthesia glp-1 receptor agonist 2023 Full article: risk and strategic approach for patients receiving agonists undergoing elective surgery The impact of glucagon-like peptide-1
Description
Huang, J
Zhang YS, Zheng YD, Yuan Y, Chen SC, Xie BC
In the interim analysis of a phase III study (REGENERATE trial) at 18 months, 931 NASH patients with stage 23 fibrosis were randomly assigned to placebo and showed significant fibrosis improvement without NASH deterioration
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
Market Restraints Gastrointestinal Adverse Effects and Stringent Regulatory Requirements Restrain Market Expansion GLP-1 receptor agonists are associated with gastrointestinal side effects such as nausea, vomiting, diarrhea, and reduced appetite, particularly during treatment initiation and dose escalation
